Nahon J L
Laboratoire d'Enzymologie CNRS, Gif-sur-Yvette, France.
Biochimie. 1987 May;69(5):445-59. doi: 10.1016/0300-9084(87)90082-4.
Albumin and alpha-fetoprotein (AFP) are two plasma proteins synthesized by the liver and the yolk sac. The production of these major proteins is subject to considerable and characteristic variations during both the course of development and hepatic carcinogenesis. It is therefore a system of choice for the analysis of genetic expression during normal differentiation and the cancerous state of eukaryotic cells. The knowledge of regulatory mechanisms at the cellular and molecular levels of the albumin and AFP genes has recently made great progress: 1) the cells which are responsible for the synthesis of albumin and AFP in the liver and other organs have been defined by conjointly using in vitro and in vivo molecular hybridization techniques; 2) the organization of these genes and their adjoining regions has been established in the rat, the mouse and man; 3) the level at which the synthesis of these two proteins is regulated has been determined; it is the transcriptional level. The transcriptional regulation of the albumin and AFP genes could be the result of genome and/or chromatin conformation level modifications. Different groups have shown that: 1) the global structure of the albumin and AFP genes does not change during the course of development and hepatic carcinogenesis; 2) modifications at the level of the methylation of certain specific cytosines could be associated with the variations in the transcription of these genes; 3) global or local (hypersensitive sites with DNase I) changes of chromatin conformation could be correlated to the potential or the overt activity of the transcription of these genes. Very recently certain 'regulatory' regions having cis 'enhancer' or 'silencer' properties have been detected upstream from the albumin and AFP genes. These regions are hypothesized to be DNA 'target' sequences on which trans-acting regulatory factors are fixed and which control the transcription of these genes. Starting from the framework of this recent work, a model of albumin and AFP gene regulation is proposed.
白蛋白和甲胎蛋白(AFP)是由肝脏和卵黄囊合成的两种血浆蛋白。在发育过程和肝癌发生过程中,这些主要蛋白质的产生会发生显著且具有特征性的变化。因此,它是分析真核细胞正常分化和癌变状态下基因表达的理想系统。近年来,在白蛋白和AFP基因的细胞和分子水平调控机制方面取得了重大进展:1)通过联合使用体外和体内分子杂交技术,已确定了肝脏和其他器官中负责合成白蛋白和AFP的细胞;2)已在大鼠、小鼠和人类中确定了这些基因及其相邻区域的结构;3)已确定了这两种蛋白质合成的调控水平,即转录水平。白蛋白和AFP基因的转录调控可能是基因组和/或染色质构象水平修饰的结果。不同的研究小组表明:1)白蛋白和AFP基因的整体结构在发育过程和肝癌发生过程中不会改变;2)某些特定胞嘧啶甲基化水平的修饰可能与这些基因转录的变化有关;3)染色质构象的整体或局部(对DNase I敏感的位点)变化可能与这些基因转录的潜在或明显活性相关。最近,在白蛋白和AFP基因上游检测到了具有顺式“增强子”或“沉默子”特性的某些“调控”区域。这些区域被认为是DNA“靶”序列,反式作用调控因子可与之结合并控制这些基因的转录。基于这项最新研究的框架,提出了白蛋白和AFP基因调控模型。